カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

カルメット-ゲラン桿菌ワクチンの世界市場2022：免疫型、治療型

◆英語タイトル：Global Bacillus Calmette Guerin Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19168 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：110 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

カルメット-ゲラン桿菌ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のカルメット-ゲラン桿菌ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

カルメット-ゲラン桿菌ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫型、治療型

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のカルメット-ゲラン桿菌ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、AJ Vaccines、Serum Institute of India、Intervax、GSBPL、Statens Serum Institute、Biomed Lublin、ANLIS Malbran、Fundação Ataulpho de Paiva、BB-NCIPD、Taj Pharmaceuticals、Bio Farma、Microgen、Torlakinstitut、Institut Pasteur de Tunis、IVAC

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カルメット-ゲラン桿菌ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルメット-ゲラン桿菌ワクチンメーカーの企業概要、2019年～2022年までのカルメット-ゲラン桿菌ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルメット-ゲラン桿菌ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別カルメット-ゲラン桿菌ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのカルメット-ゲラン桿菌ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカルメット-ゲラン桿菌ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびカルメット-ゲラン桿菌ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、カルメット-ゲラン桿菌ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- カルメット-ゲラン桿菌ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：免疫型、治療型
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のカルメット-ゲラン桿菌ワクチン市場規模・予測
- 世界のカルメット-ゲラン桿菌ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、AJ Vaccines、Serum Institute of India、Intervax、GSBPL、Statens Serum Institute、Biomed Lublin、ANLIS Malbran、Fundação Ataulpho de Paiva、BB-NCIPD、Taj Pharmaceuticals、Bio Farma、Microgen、Torlakinstitut、Institut Pasteur de Tunis、IVAC
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫型、治療型
・用途別分析2017年-2028年：病院、診療所、その他
・カルメット-ゲラン桿菌ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルメット-ゲラン桿菌ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルメット-ゲラン桿菌ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルメット-ゲラン桿菌ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・カルメット-ゲラン桿菌ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Bacillus Calmette Guerin Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bacillus Calmette Guerin Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Bacillus Calmette Guerin Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Type segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bacillus Calmette Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, and AJ Vaccines, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bacillus Calmette Guerin Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Type
Therapy Type
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Bacillus Calmette Guerin Vaccine market are listed below:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacillus Calmette Guerin Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bacillus Calmette Guerin Vaccine, with price, sales, revenue and global market share of Bacillus Calmette Guerin Vaccine from 2019 to 2022.
Chapter 3, the Bacillus Calmette Guerin Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacillus Calmette Guerin Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bacillus Calmette Guerin Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bacillus Calmette Guerin Vaccine.
Chapter 13, 14, and 15, to describe Bacillus Calmette Guerin Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Bacillus Calmette Guerin Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bacillus Calmette Guerin Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Bacillus Calmette Guerin Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bacillus Calmette Guerin Vaccine Market Size & Forecast
1.4.1 Global Bacillus Calmette Guerin Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bacillus Calmette Guerin Vaccine Sales in Volume (2017-2028)
1.4.3 Global Bacillus Calmette Guerin Vaccine Price (2017-2028)
1.5 Global Bacillus Calmette Guerin Vaccine Production Capacity Analysis
1.5.1 Global Bacillus Calmette Guerin Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Bacillus Calmette Guerin Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacillus Calmette Guerin Vaccine Market Drivers
1.6.2 Bacillus Calmette Guerin Vaccine Market Restraints
1.6.3 Bacillus Calmette Guerin Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Bacillus Calmette Guerin Vaccine Product and Services
2.1.4 Merck Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product and Services
2.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product and Services
2.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Product and Services
2.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AJ Vaccines
2.5.1 AJ Vaccines Details
2.5.2 AJ Vaccines Major Business
2.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Product and Services
2.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Product and Services
2.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Intervax
2.7.1 Intervax Details
2.7.2 Intervax Major Business
2.7.3 Intervax Bacillus Calmette Guerin Vaccine Product and Services
2.7.4 Intervax Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GSBPL
2.8.1 GSBPL Details
2.8.2 GSBPL Major Business
2.8.3 GSBPL Bacillus Calmette Guerin Vaccine Product and Services
2.8.4 GSBPL Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Statens Serum Institute
2.9.1 Statens Serum Institute Details
2.9.2 Statens Serum Institute Major Business
2.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product and Services
2.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Biomed Lublin
2.10.1 Biomed Lublin Details
2.10.2 Biomed Lublin Major Business
2.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Product and Services
2.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 ANLIS Malbran
2.11.1 ANLIS Malbran Details
2.11.2 ANLIS Malbran Major Business
2.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product and Services
2.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Fundação Ataulpho de Paiva
2.12.1 Fundação Ataulpho de Paiva Details
2.12.2 Fundação Ataulpho de Paiva Major Business
2.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product and Services
2.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 BB-NCIPD
2.13.1 BB-NCIPD Details
2.13.2 BB-NCIPD Major Business
2.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Product and Services
2.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business
2.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product and Services
2.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bio Farma
2.15.1 Bio Farma Details
2.15.2 Bio Farma Major Business
2.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Product and Services
2.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Microgen
2.16.1 Microgen Details
2.16.2 Microgen Major Business
2.16.3 Microgen Bacillus Calmette Guerin Vaccine Product and Services
2.16.4 Microgen Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Torlakinstitut
2.17.1 Torlakinstitut Details
2.17.2 Torlakinstitut Major Business
2.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Product and Services
2.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Institut Pasteur de Tunis
2.18.1 Institut Pasteur de Tunis Details
2.18.2 Institut Pasteur de Tunis Major Business
2.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product and Services
2.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 IVAC
2.19.1 IVAC Details
2.19.2 IVAC Major Business
2.19.3 IVAC Bacillus Calmette Guerin Vaccine Product and Services
2.19.4 IVAC Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bacillus Calmette Guerin Vaccine Breakdown Data by Manufacturer
3.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bacillus Calmette Guerin Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bacillus Calmette Guerin Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Bacillus Calmette Guerin Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Bacillus Calmette Guerin Vaccine Manufacturer Market Share in 2021
3.5 Global Bacillus Calmette Guerin Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bacillus Calmette Guerin Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bacillus Calmette Guerin Vaccine Market Size by Region
4.1.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2028)
4.2 North America Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.3 Europe Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.5 South America Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Bacillus Calmette Guerin Vaccine Revenue by Type (2017-2028)
5.3 Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Bacillus Calmette Guerin Vaccine Revenue by Application (2017-2028)
6.3 Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
7.2 North America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
7.3 North America Bacillus Calmette Guerin Vaccine Market Size by Country
7.3.1 North America Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
8.2 Europe Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
8.3 Europe Bacillus Calmette Guerin Vaccine Market Size by Country
8.3.1 Europe Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Bacillus Calmette Guerin Vaccine Market Size by Region
9.3.1 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
10.2 South America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
10.3 South America Bacillus Calmette Guerin Vaccine Market Size by Country
10.3.1 South America Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Bacillus Calmette Guerin Vaccine Market Size by Country
11.3.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bacillus Calmette Guerin Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bacillus Calmette Guerin Vaccine
12.3 Bacillus Calmette Guerin Vaccine Production Process
12.4 Bacillus Calmette Guerin Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bacillus Calmette Guerin Vaccine Typical Distributors
13.3 Bacillus Calmette Guerin Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ カルメット-ゲラン桿菌ワクチンの世界市場2022：免疫型、治療型(Global Bacillus Calmette Guerin Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

カルメット-ゲラン桿菌ワクチンの世界市場2022：免疫型、治療型

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp